Canada and UK's biotech trade groups BIOTECanada and BIA to strengthen cross-Atlantic cooperation

28 June 2011

BIOTECanada and BioIndustry Association (BIA), the industry associations representing the bioscience sectors of Canada and the UK, respectively, have agreed to work together to increase opportunities for companies.

The two trade associations yesterday signed a Memorandum of Understanding at the BIO 2011 Convention in Washington, which aims to strengthen collaboration between the biotechnology sectors in the two nations. These two nations have a history of collaboration in many sectors. Recognizing the biotechnology industry as an economic driver of our current and future economy, great benefits exist in a strategic partnership between Canada and the UK.

“The BIA is delighted to have established this partnership with BIOTECanada and we look forward to working together with them in future. This collaboration recognises the significance of the Canadian biotech sector and its potential for partnerships between our members and BIOTECanada’s members,” said BIA chief executive Nigel Gaymond.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology